156 related articles for article (PubMed ID: 37349991)
1. Single-cell analysis reveals the multiple patterns of immune escape in the nasopharyngeal carcinoma microenvironment.
Lin Q; Zhou Y; Ma J; Han S; Huang Y; Wu F; Wang X; Zhang Y; Mei X; Ma L
Clin Transl Med; 2023 Jun; 13(6):e1315. PubMed ID: 37349991
[TBL] [Abstract][Full Text] [Related]
2. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma.
Zhao J; Guo C; Xiong F; Yu J; Ge J; Wang H; Liao Q; Zhou Y; Gong Q; Xiang B; Zhou M; Li X; Li G; Xiong W; Fang J; Zeng Z
Cancer Lett; 2020 May; 477():131-143. PubMed ID: 32061950
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma.
Chen YP; Yin JH; Li WF; Li HJ; Chen DP; Zhang CJ; Lv JW; Wang YQ; Li XM; Li JY; Zhang PP; Li YQ; He QM; Yang XJ; Lei Y; Tang LL; Zhou GQ; Mao YP; Wei C; Xiong KX; Zhang HB; Zhu SD; Hou Y; Sun Y; Dean M; Amit I; Wu K; Kuang DM; Li GB; Liu N; Ma J
Cell Res; 2020 Nov; 30(11):1024-1042. PubMed ID: 32686767
[TBL] [Abstract][Full Text] [Related]
4. scRNA+TCR+BCR-seq revealed the proportions and gene expression patterns of dual receptor T and B lymphocytes in NPC and NLH.
Yao Y; Wang H; Xu Y; Zhang L; Liu R
Biochem Biophys Res Commun; 2024 May; 709():149820. PubMed ID: 38547605
[TBL] [Abstract][Full Text] [Related]
5. E2F1-EP300 co-activator complex potentiates immune escape in nasopharyngeal carcinoma through the mediation of MELK.
Wang Q; Yu Q; Liu Y
Histol Histopathol; 2024 Apr; 39(4):511-523. PubMed ID: 37728155
[TBL] [Abstract][Full Text] [Related]
6. Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma.
Wang L; Li S; Li X; Zhuo G; Zhang Q; Liu G; Pan Y
Neoplasia; 2024 Apr; 50():100980. PubMed ID: 38382442
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma.
Chen C; Wang C; Pang R; Liu H; Yin W; Chen J; Tao L
J Transl Med; 2023 Apr; 21(1):278. PubMed ID: 37098551
[TBL] [Abstract][Full Text] [Related]
8. The immune escape mechanism of nasopharyngeal carcinoma.
Li X; Guo Y; Xiao M; Zhang W
FASEB J; 2023 Jul; 37(7):e23055. PubMed ID: 37358482
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma.
Li W; Lv S; Liu G; Lu N; Jiang Y; Liang H; Xia W; Xiang Y; Xie C; He J
Front Immunol; 2023; 14():1124066. PubMed ID: 36860875
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma.
Gong L; Kwong DL; Dai W; Wu P; Li S; Yan Q; Zhang Y; Zhang B; Fang X; Liu L; Luo M; Liu B; Chow LK; Chen Q; Huang J; Lee VH; Lam KO; Lo AW; Chen Z; Wang Y; Lee AW; Guan XY
Nat Commun; 2021 Mar; 12(1):1540. PubMed ID: 33750785
[TBL] [Abstract][Full Text] [Related]
11. M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma.
Wang Y; Peng L; Wang F
Cancer Biol Ther; 2024 Dec; 25(1):2333590. PubMed ID: 38532632
[TBL] [Abstract][Full Text] [Related]
12. E2F3 renders an immunosuppressive tumor microenvironment in nasopharyngeal carcinoma: Involvements of the transcription activation of PRC1 and BIRC5.
Wang Q; Yu Q; Liu Y
Immun Inflamm Dis; 2023 Aug; 11(8):e987. PubMed ID: 37647439
[TBL] [Abstract][Full Text] [Related]
13. Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution.
Liu Y; He S; Wang XL; Peng W; Chen QY; Chi DM; Chen JR; Han BW; Lin GW; Li YQ; Wang QY; Peng RJ; Wei PP; Guo X; Li B; Xia X; Mai HQ; Hu XD; Zhang Z; Zeng YX; Bei JX
Nat Commun; 2021 Feb; 12(1):741. PubMed ID: 33531485
[TBL] [Abstract][Full Text] [Related]
14. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
Liu Z; He J; Han J; Yang J; Liao W; Chen N
Front Immunol; 2021; 12():762243. PubMed ID: 35069534
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing.
Peng WS; Zhou X; Yan WB; Li YJ; Du CR; Wang XS; Shen CY; Wang QF; Ying HM; Lu XG; Xu TT; Hu CS
Oncoimmunology; 2022; 11(1):2026583. PubMed ID: 35096485
[TBL] [Abstract][Full Text] [Related]
16. Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment.
Jiang J; Ying H
J Exp Clin Cancer Res; 2022 Aug; 41(1):244. PubMed ID: 35964134
[TBL] [Abstract][Full Text] [Related]
17. The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma.
Li S; Dai W; Kam NW; Zhang J; Lee VHF; Ren X; Kwong DL
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610990
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes.
Liu H; Tang L; Li Y; Xie W; Zhang L; Tang H; Xiao T; Yang H; Gu W; Wang H; Chen P
Mol Cancer; 2024 Jan; 23(1):20. PubMed ID: 38254110
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma.
Ka-Yue Chow L; Lai-Shun Chung D; Tao L; Chan KF; Tung SY; Cheong Ngan RK; Ng WT; Wing-Mui Lee A; Yau CC; Lai-Wan Kwong D; Ho-Fun Lee V; Lam KO; Liu J; Chen H; Dai W; Lung ML
EBioMedicine; 2022 Dec; 86():104357. PubMed ID: 36371985
[TBL] [Abstract][Full Text] [Related]
20. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes.
Zhang L; MacIsaac KD; Zhou T; Huang PY; Xin C; Dobson JR; Yu K; Chiang DY; Fan Y; Pelletier M; Wang Y; Jaeger S; Krishnamurthy Radhakrishnan V; JeBailey L; Skewes-Cox P; Zhang J; Fang W; Huang Y; Zhao H; Zhao Y; Li E; Peng B; Huang A; Dranoff G; Hammerman PS; Engelman J; Bitter H; Zeng YX; Yao Y
Mol Cancer Res; 2017 Dec; 15(12):1722-1732. PubMed ID: 28851814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
